PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
18-Nov-2021 Xlife Sciences AG explores listing on SIX Swiss Exchange Xlife Sciences AG
18-Nov-2021 SOTIO Strengthens its Strategic Advisory Board with Esteemed Oncology Experts and Industry Veterans B3C newswire
18-Nov-2021 Eckert & Ziegler Receives Approval for Gallium-68 Generator for Brasil Eckert & Ziegler Strahlen- und Medizintechnik AG
18-Nov-2021 Well Pharmacy partners with Antibiotic Research UK in a bid to keep antibiotics working Sciad Newswire
18-Nov-2021 Roche launches cobas 5800, a new molecular diagnostics system to expand access to testing and improve patient care Roche
18-Nov-2021 Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipeline Sanofi
18-Nov-2021 Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period and Extension of Tender Offer to Acquire Acceleron Pharma Inc. Merck
18-Nov-2021 SciRhom Announces Changes to The Management Team and The Appointment of a Board of Directors B3C newswire
18-Nov-2021 ​​​​​​​Supervisory Board of Epigenomics AG Appoints Dr. Andrew Lukowiak as President and Chief Scientific Officer Epigenomics AG
18-Nov-2021 APONTIS PHARMA grows significantly faster than the overall market in the nine-month period 2021 - Revenue forecast increased APONTIS PHARMA AG
18-Nov-2021 Evotec and EQRx announce integrated drug discovery and development partnership Evotec SE
18-Nov-2021 COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH DEFINITIVE INTERIM RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A. AND DECLARE THE OFFER SUCCESSFUL Cassiopea S.p.A.
18-Nov-2021 COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH DEFINITIVE INTERIM RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A. AND DECLARE THE OFFER SUCCESSFUL Cosmo Pharmaceuticals N.V.
18-Nov-2021 M1 Kliniken AG announces financials for Q3-2021: forecasts confirmed after good development of treatment and business figures M1 Kliniken AG
18-Nov-2021 Relief Therapeutics Launches Level 1 ADR Program in the United States RELIEF THERAPEUTICS Holding AG
18-Nov-2021 HAEMATO AG reports figures for the 3rd quarter of 2021: Further increase in revenue and earnings as well as confirmation of revenue and earnings expectations for 2021 HAEMATO AG
17-Nov-2021 New Data Suggests More Doctors Spending Time Addressing COVID-19 Vaccine Misinformation As Compared To Six Months Ago B3C newswire
17-Nov-2021 ProBioGen's GlymaxX® Technology Made It Again into Clinical Phase I B3C newswire
17-Nov-2021 Watson-Marlow Fluid Technology Group Crowned Most Innovative Pharma Fluid Management Solutions Provider 2021 Sciad Newswire
17-Nov-2021 AbbVie Expands Immunology Portfolio in the European Union with the European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Active Psoriatic Arthritis AbbVie